BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20221806)

  • 1. Psychometric properties of the EORTC head and neck-specific quality of life questionnaire in disease-free Greek patients with cancer of pharynx and larynx.
    Nalbadian M; Nikolaidis V; Nikolaou A; Themelis C; Kouloulas A; Vital V
    Qual Life Res; 2010 Jun; 19(5):761-8. PubMed ID: 20221806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish.
    Jensen K; Jensen AB; Grau C
    Acta Oncol; 2006; 45(1):28-37. PubMed ID: 16464793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary psychometric validation of the Polish version of the EORTC head and neck module (QLQ-H&N35).
    Tomaszewska IM; Glowacki R; Paradowska D; Walocha E
    Folia Med Cracov; 2013; 53(1):55-63. PubMed ID: 24858331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Greek version of the University of Washington quality of life questionnaire for patients with head and neck cancer.
    Linardoutsos G; Rapidis AD; Lowe D; Bramis I; Rogers SN
    J Craniomaxillofac Surg; 2014 Jul; 42(5):601-7. PubMed ID: 24289872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers.
    Carrillo JF; Ortiz-Toledo MA; Salido-Noriega Z; Romero-Ventura NB; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Ann Surg Oncol; 2013 May; 20(5):1417-26. PubMed ID: 23108555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Urdu version of the EORTC QLQ-H&N35 (European organization for research and treatment of cancer head and neck module) quality of life tool.
    Zahid N; Martins RS; Zahid W; Azam I; Ikram M; Hassan A; Bhamani SS; Jabbar AA; Asad N; Akhtar S; Siddiqui MI; Awan MS; Ahmad K
    BMC Psychol; 2022 Aug; 10(1):194. PubMed ID: 35934706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.
    Bjordal K; de Graeff A; Fayers PM; Hammerlid E; van Pottelsberghe C; Curran D; Ahlner-Elmqvist M; Maher EJ; Meyza JW; Brédart A; Söderholm AL; Arraras JJ; Feine JS; Abendstein H; Morton RP; Pignon T; Huguenin P; Bottomly A; Kaasa S
    Eur J Cancer; 2000 Sep; 36(14):1796-807. PubMed ID: 10974628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
    Singer S; Wollbrück D; Wulke C; Dietz A; Klemm E; Oeken J; Meister EF; Gudziol H; Bindewald J; Schwarz R
    Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
    Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EORTC quality of life questionnaire-head and neck 35 in Italian laryngectomized patients. European organization for research and treatment of cancer.
    Zotti P; Lugli D; Vaccher E; Vidotto G; Franchin G; Barzan L
    Qual Life Res; 2000; 9(10):1147-53. PubMed ID: 11401047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary psychometric validation of the Polish version of the EORTC elderly module (QLQ-ELD14).
    Wrazen W; Golec EB; Tomaszewska IM; Walocha E; Dudkiewicz Z; Tomaszewski KA
    Folia Med Cracov; 2014; 54(2):35-45. PubMed ID: 25648308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric evaluation of Azeri version of the head and neck cancer specific quality of life questionnaire (EORTC QLQ-H&N43).
    Davudov MM; Rahimov C; Harirchi I; Mirzajani Z; Amiraliyev N; Amiraliyev K; Rustamova N; Zebardast J; Montazeri A
    Health Qual Life Outcomes; 2020 Jul; 18(1):248. PubMed ID: 32703297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
    Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
    Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.
    Bjordal K; Hammerlid E; Ahlner-Elmqvist M; de Graeff A; Boysen M; Evensen JF; Biörklund A; de Leeuw JR; Fayers PM; Jannert M; Westin T; Kaasa S
    J Clin Oncol; 1999 Mar; 17(3):1008-19. PubMed ID: 10071296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III.
    Singer S; Araújo C; Arraras JI; Baumann I; Boehm A; Brokstad Herlofson B; Castro Silva J; Chie WC; Fisher S; Guntinas-Lichius O; Hammerlid E; Irarrázaval ME; Jensen Hjermstad M; Jensen K; Kiyota N; Licitra L; Nicolatou-Galitis O; Pinto M; Santos M; Schmalz C; Sherman AC; Tomaszewska IM; Verdonck de Leeuw I; Yarom N; Zotti P; Hofmeister D;
    Head Neck; 2015 Sep; 37(9):1358-67. PubMed ID: 24832623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.
    Jensen K; Bonde Jensen A; Grau C
    Radiother Oncol; 2006 Mar; 78(3):298-305. PubMed ID: 16524633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Polish version of the EORTC Head and Neck module (QLQ-H&N35).
    Kucharska E; Głowacki R; Bereza K; Gładysz T; Walocha E; Golec J; Tomaszewska IM
    Przegl Lek; 2016; 73(2):67-71. PubMed ID: 27197425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of health-related quality of life with EORTC QLQ-C30 and QLQ-H&N35 in Romanian laryngeal cancer patients.
    Dinescu FV; Ţiple C; Chirilă M; Mureşan R; Drugan T; Cosgarea M
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2735-40. PubMed ID: 26511987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.